JAN (NYSE:JAN) Updates FY 2026 Earnings Guidance

Key Points

• FY2026 EPS guidance: JAN issued an EPS range of 0.930–0.970, roughly in line with the consensus of 0.950, while the company did not provide revenue guidance.
• Significant insider buying: COO Jeffrey H. Miller bought 7,500 shares and Director John V. Arabia bought 60,000 shares at $20.00 each, part of insiders acquiring 187,000 shares (~$3.74M) over the past 90 days; insiders now own about 3% of the company.
• Analyst sentiment and market context: Multiple firms initiated coverage with mostly positive ratings and a consensus price target of $27.27 ("Moderate Buy"); the stock traded at $26.25 on below-average volume, has a negative trailing P/E and a beta of ~2.16, signaling higher volatility.

JAN (NYSE:JAN - Get Free Report) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 0.930-0.970 for the period, compared to the consensus earnings per share estimate of 0.950. The company issued revenue guidance of -.

JAN Price Performance

JAN stock traded down $0.07 on Tuesday, hitting $26.25. The company's stock had a trading volume of 413,965 shares, compared to its average volume of 1,123,063. JAN has a 1 year low of $22.76 and a 1 year high of $26.74. The company has a market cap of $6.74 billion, a price-to-earnings ratio of -62.29 and a beta of 2.16.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. Wells Fargo & Company assumed coverage on shares of JAN in a research report on Tuesday, April 14th. They set an "overweight" rating and a $27.00 price objective for the company. Barclays assumed coverage on shares of JAN in a research report on Tuesday, April 14th. They set an "overweight" rating and a $26.00 price objective for the company. The Goldman Sachs Group assumed coverage on shares of JAN in a research report on Tuesday, April 14th. They set a "neutral" rating and a $27.00 price objective for the company. KeyCorp assumed coverage on shares of JAN in a research report on Tuesday, April 14th. They set an "overweight" rating and a $28.00 price objective for the company. Finally, BNP Paribas Exane assumed coverage on shares of JAN in a research report on Tuesday, April 14th. They set an "outperform" rating and a $27.00 price objective for the company. Ten equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, JAN has a consensus rating of "Moderate Buy" and a consensus price target of $27.27.

Insider Buying and Selling at JAN

In related news, COO Jeffrey H. Miller purchased 7,500 shares of the stock in a transaction dated Monday, March 23rd. The shares were acquired at an average cost of $20.00 per share, with a total value of $150,000.00. Following the purchase, the chief operating officer directly owned 7,500 shares in the company, valued at $150,000. This trade represents a ∞ increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director John V. Arabia purchased 60,000 shares of the stock in a transaction dated Monday, March 23rd. The shares were bought at an average cost of $20.00 per share, for a total transaction of $1,200,000.00. Following the completion of the purchase, the director owned 67,500 shares in the company, valued at approximately $1,350,000. This trade represents a 800.00% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last 90 days, insiders acquired 187,000 shares of company stock worth $3,740,000. Company insiders own 3.00% of the company's stock.

JAN News Roundup

Here are the key news stories impacting JAN this week:

• Positive Sentiment: Increased coverage/visibility — a comparison piece that pits JAN against peer Fermi may draw fresh investor attention and fresh flows into the name as readers re‑evaluate relative value; that attention can be constructive if it leads to renewed analyst checks or fund buys. Comparing JAN NYSE: JAN and Fermi NASDAQ: FRMI
• Neutral Sentiment: Published comparison article — the piece on JAN vs. FRMI provides context (valuation, business model, risk profile). It’s informational and may prompt short-term positioning changes, but it does not appear to contain company-specific catalysts (earnings, guidance, M&A) that would clearly move fundamentals. Comparing JAN NYSE: JAN and Fermi NASDAQ: FRMI
• Negative Sentiment: Low intraday liquidity — today’s volume (~172k) is far below JAN’s average volume (~1.12M), which can exaggerate price moves and discourage larger traders. This likely contributed to the modest downward move.
• Negative Sentiment: Unprofitable/valuation signal — JAN shows a negative P/E, indicating it’s not profitable on trailing earnings; that raises sensitivity to any weak operational news and can cap investor appetite until profitability or clearer growth prospects emerge.
• Negative Sentiment: Higher volatility profile — the stock’s beta (~2.16) suggests it will swing more than the market, so in a risk‑off session investors may trim positions faster than for lower‑beta names.

JAN Company Profile

Upon completion of this offering, we will be the only U.S. publicly traded REIT focused exclusively on the senior housing sector and the only U.S. publicly traded REIT whose entire portfolio is owned and operated under RIDEA structures. We have an initial portfolio consisting of 34 senior housing communities, comprised of 10,422 units as of December 31, 2025. Our communities are located primarily in major retirement markets across 10 states, with units in Florida and Texas representing 69% of the total units as of December 31, 2025.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.